Pfizer (NYSE:PFE) leads in biopharmaceuticals and vaccines, with strong performance reflected in the S&P 500 index.

The post Clinical Trials Show Moderna's New mRNA Flu Vaccine Is Safe and Effective. FDA Won't Even Consider It. appeared ...

Oyo State began mass vaccination of animals against major Transboundary Animal Diseases (TADs) as part of a nationwide effort to strengthen animal health services, boost livestock productivity, and ...

Racotumomab, a vaccine for advanced non-small cell lung cancer, has shown promise in clinical trials. A study published in ...

New Delhi, The Central Drugs Standard Control Organization along with State Licensing Authority has investigated the circulation of batch specific spurious rabies vaccine in India, resulting in arrest ...

New Hampshire Republican Party's push to end mandatory vaccinations for schoolchildren will be discussed in a legislative committee hearing.

Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and MRNA and see which is better for you.

Vaxcyte, Inc. (NASDAQ: PCVX), with a market capitalization of around $7 billion, is trading higher on Friday. The stock’s positive movement comes as Vaxcyte is advancing its VAX-31 vaccine trials ...

The use of LuerVax® and Spray Divider™ support Aptar’s commitment to advancing drug delivery and next-generation vaccine development, backed by comprehensive regulatory and technical expertise CRYSTAL ...

Current vaccination rates among U.S. school-age children are too low to maintain effective herd immunity against several preventable diseases. Coverage for key vaccines such as MMR (measles, mumps, ...